Cancer innovation shaped by Africa — for the world
Yemaachi is creating and harnessing the world’s most robust cancer knowledge base to develop the next generation of cancer drugs that are effective in diverse populations.
Our work is dedicated to transforming lives through inclusive, innovative science.
Yemaachi is pioneering clinical genomic research across Africa across multiple cancer types.
Yemaachi is supported by a robust network of partners and collaborators in the public, private, and non-profit sectors from all over the globe.
All are committed to our vision of diversifying and improving precision oncology.
Yemaachi has an unmatched global team with African roots
Yemaachi’s team is made up of scientists, engineers, and business operators with global expertise and African experience building a global biotech company with African roots.
